Mental disorders represent a worldwide public health concern. Psychotherapies and
pharmacotherapies are recommended as first line treatments. However, evidence has …

Background Misconceptions about ADHD stigmatize affected people, reduce credibility of
providers, and prevent/delay treatment. To challenge misconceptions, we curated findings …

Background There is evidence to suggest that the broad discrepancy in the ratio of males to
females with diagnosed ADHD is due, at least in part, to lack of recognition and/or referral …

While behavioral interventions remain the mainstay of treatment of autism spectrum disorder
(ASD), several potential targeted treatments addressing the underlying neurophysiology of …

Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder
characterized by inattention, hyperactivity, and impulsivity, causing functional impairment. Its …

Importance Reported increases in attention-deficit/hyperactivity disorder (ADHD) diagnoses
are accompanied by growing debate about the underlying factors. Although overdiagnosis is …

Individuals with substance use disorders (SUDs) are at increased risk for COVID‐19
infection and for adverse outcomes of the infection. Though vaccines are highly effective …

Background Attention-deficit/hyperactivity disorder (ADHD) is among the most common
psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD …

Background Attention-deficit hyperactivity disorder (ADHD) is a common paediatric
neurodevelopmental disorder with substantial effect on families and society. Alternatives to …

Pharmacologic Treatment of ADHD Amphetamines and methylphenidate and, less often,
nonstimulants (atomoxetine, clonidine, and guanfacine) are used to treat ADHD …